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lysosomal targeting of the receptor, to maintain contractile VSMC phenotype and vascular stability. Our study reveals novel insight into the mechanism by which Tβ4 controls LRP1mediated VSMC responses to protect against vascular disease. Given that LRP1 has been implicated in multiple GWAS as a key regulator of vascular protection, identification of an important molecular regulator may enable the development of novel therapies for modulation of VSMC phenotypic switching and disease progression.
A role for Tβ β β β4 in maintenance of adult vascular stability
Whilst vascular defects cause lethality in a proportion of Tmsb4x/Tβ4 null embryos (36% of Tβ4 -/Y males; 16% of Tβ4 -/females) (7) , most survive to adulthood. This prompted us to investigate whether vessel structure and function were entirely normal in viable adults. Due to the higher mortality in male embryos, we focussed our studies primarily on male mice. Compared with control Tβ4 +/Y aortas, Tβ4 -/Y aortas of [12] [13] [14] [15] [16] week old mice were significantly dilated (mean 1.5fold, determined histologically from both abdominal (AA) and thoracic (TA) sections; Figure 1 , A-B) and a 1.4-fold elevation of systemic vascular compliance (stroke volume/pulse pressure) was revealed by combined MRI and arterial blood pressure measurements ( Figure 1C ). Moreover, aberrant elastin lamellar integrity suggested severely compromised vascular stability (3.6-fold more elastin breaks per section and higher elastin damage score, systematically assessed according to a previously defined scoring system (19) Figure 1G ). Due to the requirement for Tβ4 in VSMC differentiation ( (7, 8, 20) ), we assessed the phenotype of medial layer VSMCs by measuring expression of 
Tβ4 interacts with the vasculoprotective endocytic receptor, LRP1
To gain insight into the possible mechanisms by which Tβ4 maintains vascular health, we performed a yeast two hybrid screen to identify putative binding partners from an E11.5 murine embryonic library. A leading candidate was Low density lipoprotein receptor related protein 1 (LRP1), associated in human (12) (13) (14) and animal studies (15, 16) with protection against AAA and atherosclerosis. Two independent clones expressing regions of the intracellular domain of LRP1 were identified among the "prey" plasmids after stringent selection. Although we could not reproducibly co-immunoprecipitate Tβ4-LRP1 from murine aorta or MOVAS-1, a murine aortic VSMC line, we validated close association of the proteins (<40nm) by proximity ligation assay (PLA), consistent with the possibility of a weak or transient interaction, or an indirect association via a complex. Foci of Tβ4-LRP1 PLA signals were detected within medial VSMCs of murine aorta, at baseline ( Figure 3A ), as well as in disease (not shown). Moreover, conservation across species and clinical relevance was confirmed by detection of PLA signals in human VSMCs, both in aneurysmal aorta from AAA patients enrolled in the Oxford Abdominal Aortic Aneurysm Study (OxAAA study (26) ); Figure 3B ) and healthy vessels (matched omental artery samples from the same patients). Specificity for the PLA was ensured by lack of signal in -/Y Tβ4 null aortas ( Figure   3A ) and with omission of the LRP1 antibody ( Figure 3B ). While PLA signals were more abundant in omental arteries than AAA samples, inferences about disease relationship cannot be made, due to the small sample size and potentially compromised tissue integrity in the diseased vessels.
Nevertheless, these observations collectively support a potential role for Tβ4 in regulating VSMC function via LRP1. We examined localisation of Tβ4-LRP1 foci more closely in primary murine aortic VSMCs. By immunofluorescence, LRP1 localised to punctate structures, consistent with its known incorporation into endocytic vesicles ( Figure 3C ). While Tβ4 was distributed throughout the cytoplasm, as expected, we observed strong puncta, suggesting that it may also localise to endosomal compartments. Indeed, Tβ4-LRP1 PLA signals partially overlapped with early endosomes, detected by expression of EEA1 ( Figure 3D ).
Loss of Tβ4 predisposes to vascular disease
Our assessment of the Tβ4 -/Y and Myh11 CreERT2 ; Hprt Tβ4shRNA vasculature at baseline reveals defects that phenocopy those previously reported in smooth muscle-specific LRP1 -/mice (16, 17, 27 Figure 2 ). These observations not only support a common pathway, but also suggest that Tβ4KO mice may, like LRP1 nulls, be similarly predisposed to develop aortic aneurysm and atherosclerosis. We tested this supposition, firstly in a model of hypercholesterolaemia, by crossing onto the ApoE -/background (28) and feeding a 'Western diet' (WD; 21.4% fat; 0.2% cholesterol) for 12 weeks. Atherosclerotic plaques in the aortic sinus ( Figure 4A -B) and descending thoracic aorta ( Figure 4C ) were significantly larger in Tβ4 -/Y ; ApoE -/mice than in Tβ4 +/Y ; ApoE -/littermate controls and were comparable in size to those of a smooth muscle-specific Lrp1 mutant (Myh11 Cre ; Lrp1 fl/fl ; ApoE -/-; tamoxifen-induced at 3 weeks of age).
Increased plaque size did not correlate with an increase in weight gain or in cholesterol levels in Tβ4 -/Y ; ApoE -/mice, compared with Tβ4 +/Y ; ApoE -/-, although mice of both genotypes weighed more than Myh11 Cre ; Lrp1 fl/fl ; ApoE -/-, both at baseline and after high fat feeding (Supplemental Figure 3 ).
We tracked VSMC phenotype over the course of WD feeding and, after 7 weeks, the medial layer VSMCs of Tβ4 -/Y ; ApoE -/mice displayed a pronounced alteration in morphology, with loss of their characteristic elongated shape and acquisition of a smaller, more rounded appearance( Figure   4D ). This was accompanied by a shift in the ratio of synthetic (L-caldesmon and vimentin increased) over contractile markers (αSMA, Sm22α and Myh11 decreased), determined by immunofluorescence and qRT-PCR ( Figure 4D and E, respectively). Tβ4 +/Y ; ApoE -/-VSMCs underwent a similar shift, only this occurred more gradually, becoming noticeable from 9 weeks' WD, once plaques were already established ( Figure 4D ). We measured fibrous cap thickness, relative to lesion thickness, after 12 weeks and, whilst this was comparable between genotypes ( Figure 4 , D, F), the caps of Tβ4 -/Y ; ApoE -/plaques were composed of cells expressing exclusively synthetic markers, such as L-caldesmon ( Figure 4D ). In comparison, control Tβ4 +/Y ; ApoE -/cap cells retained higher levels of contractile markers, such as αSMA ( Figure 4D ). Consistent with dedifferentiation and acquisition of a synthetic phenotype, medial VSMCs were significantly more proliferative, as determined by increased EdU incorporation between weeks 5 and 7 of WD feeding ( Figure 4G ); in contrast, cells within the plaque showed no difference in proliferation between genotypes (Supplemental Figure 4A ; quantified in Figure 4G ). These cells, confirmed to be mostly macrophages/foam cells, based on CD68 expression (Supplemental Figure 4B figure 6 ). Interestingly, in female mice, as compared to male mice, increased plaque size did correlate with increased weight gain in Tβ4 -/-; ApoE -/mice, compared with Tβ4 +/+ ; ApoE -/-. Taken together, these studies suggest that atherogenesis is accelerated in Tβ4 null mice, regardless of gender, and is underpinned by an advanced VSMC contractile-synthetic phenotype shift, which closely recapitulates the phenotype associated with loss of LRP1.
We next determined whether loss of Tβ4 similarly predisposed to abdominal aneurysm, using the well-characterised model of Angiotensin II infusion (Ang II; 1mg/kg/day), via a subcutaneously implanted osmotic mini pump for up to 10 days. Analysis of whole mount aortas revealed an increased susceptibility of Tβ4 -/Y mice to aneurysm, compared with Tβ4 +/Y controls ( Figure 5A ).
Phenotypes ranged from more pronounced ascending and descending aortic aneurysm (defined as >1.5-fold dilatation; mild) to abdominal aortic rupture, haematoma formation and death in <5 days (severe) (quantified in Figure 5B ; examples of ruptures shown in Supplemental Figure 7 ).
Although rare (<10%), dissections were detectable in Tβ4 -/Y as blood tracking into the adventitial matrix or between medial and adventitial layers; Supplemental Figure 7 , death at day 8). Given the prominent role of inflammation in driving aneurysm progression with AngII treatment and numerous anti-inflammatory roles ascribed to Tβ4 (23, 24, 30) , we also investigated susceptibility in tamoxifen-dosed Myh11 CreERT2 ; Hprt Tβ4shRNA knockdown mice, alongside Myh11 CreERT2 ; Hprt +/+ controls ( Figure 5A ) and Myh11 CreERT2 ; Lrp1 fl/fl mice, in order to avoid disrupting Tβ4-LRP1 function in immune cells. Similar to global Tβ4 knockouts, VSMC-specific Tβ4 knockdown mice displayed an increased incidence of rupture (Supplemental Figure 7) , as well as aortic aneurysms and a higher mortality rate over the 10 day time course (incidence rates quantified in Figure 5B and days' AngII). The prominent morphological alterations were accompanied by increased expression of synthetic maker, L-caldesmon ( Figure 5F ). After 10 days' infusion, a further phenotype shift was observed, along with a greater VSMC loss, in Tβ4 -/Y , Myh11 CreERT2 ;
Hprt Tβ4shRNA and Myh11 Cre ; Lrp1 fl/fl aortas, compared with controls ( Figure 5G ). Collectively, these data demonstrate that loss of Tβ4 predisposes to aortic aneurysm, in the same way as loss of LRP1. Accelerated disease progression in mutants appeared not to relate to exacerbated inflammation, but rather to the more rapid VSMC phenotypic switch and degeneration of the elastin lamellae.
LRP1-controlled growth factor signalling is dysregulated in the absence of Tβ β β β4
The VSMC-autonomous protective functions of LRP1 have been attributed, in part, to its role in regulating PDGFRβ endocytosis and signalling. We therefore sought further evidence for Figure 6G ). Of note, although only nuclear P-ERK signals were quantified above, a striking accumulation of perinuclear P-ERK was also apparent in Tβ4 -/Y , but not Tβ4 +/Y , VSMCs ( Figure   6E ); association of Tyrosine phosphorylated ERK with Golgi occurs during the G2/M phase of the cell cycle (35) , further evidence of enhanced proliferation in Tβ4 -/Y VSMCs. By contrast, increased sensitivity to PDGF-BB did not correlate with enhanced migration, as assessed by scratch wound assay (Supplemental Figure 9 ); in fact, Tβ4 -/Y VSMCs migrated significantly more slowly than Tβ4 +/Y VSMCs. As this result was unexpected, we additionally compared migration rates in Myh11 Cre ; Lrp1 fl/fl VSMCs, which are similarly known to be hypersensitive to PDGF-BB, and found their migration to be likewise reduced compared with controls.
Tβ β β β4 modulates LRP1-PDGFRβ β β β signalling via receptor-mediated endocytosis
As a proposed co-recepetor(31), endocytosis of LRP1 is necessary for PDGFRβ kinase activity (18) . From endosomes, the LRP1-PDGFRβ complex may be recycled to the cell membrane or targeted for lysosomal degradation. Regulating receptor trafficking critically determines sensitivity to PDGF ligands and magnitude of downstream cellular responses. We, therefore, sought to investigate a role for Tβ4 in endocytosis of the LRP1-PDGFRβ complex, to determine if this may, at least in part, explain the effects of Tβ4 on PDGF-BB signalling described above. Initial studies were performed in MOVAS-1 cells, with siRNA-mediated knockdown of Tβ4 (reduced to 10.1 ± 7.9% at the mRNA level across all experiments; Supplemental Figure 10 ).
Western blotting confirmed a similarly enhanced and more sustained activation of components of the PDGFRβ pathway in serum-starved, Tβ4 siRNA-treated MOVAS-1, with addition of 20ng/ml PDGF-BB ( Figure 7A ). Y1021-phosphorylated PDGFRβ and S473 phosphorylated Akt were significantly enhanced, although phosphorylated p42/p44 was unaffected in knocked down MOVAS-1 ( Figure 7B ). Total PDGFRβ levels declined steadily over the 60 minutes, consistent with lysosomal targeting and degradation and decline was notably more gradual in Tβ4 knockdown cells, albeit this was not significant ( Figure 7B ). In parallel, we performed surface biotinylation assays to measure levels of LRP1 and PDGFRβ at the cell surface over the same 
Discussion
Collectively, our results demonstrate a postnatal requirement for Tβ4 in VSMCs to maintain differentiated, contractile phenotype, both at baseline (homeostasis) and in the context of aortic diseases. Tβ4 -/Y ; ApoE-/-mice developed more unstable atherosclerotic plaques, in the aortic root and descending aorta. Similarly, global and VSMC-specific Tβ4 null mice displayed increased susceptibility to aortic aneurysm and a higher incidence of dissection, rupture and mortality. Accelerated disease progression was characterized by augmented contractilesynthetic VSMC switching and dysregulated PDGFRβ signaling, which may, at least in part, result from a failure to functionally regulate its endocytic co-receptor, LRP1. Consistent with this, the defects we describe in Tβ4 null mice closely phenocopy those reported with VSMC-specific loss of LRP1, both during development (38) and in disease (16, 17, 27) . Of note, that the Myh11 CreERT2 ;
Lrp1 fl/fl mice described herein recapitulated the published LRP1 phenotype, even when loss of Lrp1 was induced postnatally, confirms a maintenance role for LRP1, as with Tβ4, in vascular homeostasis, rather than persistence of developmental defects predisposing to disease. The previous studies used a constitutive sm22αCre (16, 27) , active in embryonic VSMC progenitors and, as such, did not explicitly distinguish between these possibilities, although young mice were reported not to show aortic defects (17) . Although we did not detect any overt exacerbation of inflammatory responses in global Tβ4 -/Y mice, it was important, due to the recognized roles for LRP1 and Tβ4 in endothelial cells (6, 39) and macrophages (40, 41) , to distinguish a cellautonomous VSMC role from potential paracrine contributions. However, it would be of interest to further investigate whether Tβ4 functionally regulates LRP1 in other cell types to influence vascular disease outcome.
From a clinical perspective, these findings are highly relevant. Genome-wide association studies have identified LRP1 variants as major risk loci for AAA (12) , carotid artery (13) and coronary artery disease (14) . Tβ4 is the most abundant transcript in healthy and AAA aorta(5), yet its roles in vascular protection and regulation of LRP1-mediated growth factor signalling had not been recognised. Our study provides a mechanism by which Tβ4 controls LRP1-mediated VSMC responses to protect against vascular disease. The significance of VSMC phenotypic switching in disease is still not fully resolved, as recently discussed in (42) . While abnormal proliferation and migration of VSMCs drives early lesion formation and may contribute macrophage-like cells to the plaque, VSMCs are beneficial in advanced plaques, for preventing fibrous cap rupture.
Understanding VSMC heterogeneity, and identifying the regulators of contractile-synthetic switching, may enable the fine tuning of VSMC phenotypes that are beneficial for repair.
Interestingly, while loss of Tβ4 and LRP1 augmented PDGFRβ signaling and promoted proliferation, in vitro VSMC migration was, in our hands, inhibited. Although this finding is inconsistent with some studies demonstrating enhanced VSMC migration upon loss of LRP1 (27, 43) , others have demonstrated inhibition, confirming a requirement for LRP1 ((44, 45)), just as there is a clear requirement for Tβ4 (46) , in cell migration. Whether LRP1 promotes or inhibits migration of VSMCs appears to be dependent on extracellular matrix and ligand-binding cues (47) , as discussed in (48) . Moreover, there are likely distinct paracrine stimulatory roles for Tβ4-LRP1 as well as direct effects upon remodeling of the actin cytoskeleton(49) (50).
PDGF-BB, secreted from infiltrating macrophages during the initiating phases of aortic disease, potently drives VSMC phenotypic switching. The vasculoprotective effects of Tβ4 that we report appear to be mediated, at least in part, via LRP1-regulated growth factor signalling, specifically to control the sensitivity of VSMCs to PDGF-BB and potentially other ligands that are regulated by LRP1 (51) . Tβ4 was found to alter cellular responses to PDGF-BB by shifting the balance between receptor degradation and recycling. Further research is required to elucidate the precise mechanism(s) by which Tβ4 controls receptor trafficking and to determine whether this is limited to selected receptors, such as LRP1, or a generic regulation of endocytosis. De novo actin filament assembly is essential for endocytosis and, as an actin monomer-sequestering peptide, Tβ4 displays a biphasic effect: stimulating receptor-mediated endocytosis at low concentrations (<0.5µM) but inhibiting the process at high concentrations (10µM), consistent with actin depolymerization induced with high doses (52) . More specifically, Tβ4-mediated, membraneinduced actin polymerization was shown to be required for fusion of late endosomes and phagosomes/lysosomes, but not for fusion of early endosomes, which can proceed without actin polymerization (53) . Reduced lysosomal targeting of LRP1-PDGFRβ in our experiments is consistent with a defect in late endosome-lysosome fusion but seems an unlikely explanation for the increased partitioning to recycling endosomes. Recycling of signalling receptors occurs via a selective and carefully-regulated mechanism, which also requires actin polymerization, namely 'Actin-Stabilized Sequence-dependent Recycling Tubule (ASSERT)' scaffold formation (54), although a direct role for Tβ4 in this process has not been investigated. Thus, although there is support for a fundamental role for Tβ4 in endocytosis, given the remarkable similarity in developmental and disease phenotypes of Tβ4 and LRP1 mutants, a more selective role in regulation of LRP1-PDGFRβ by Tβ4 remains a possibility, supported by our identification of a physical interaction of LRP1-Tβ4 from a yeast two hybrid screen. While we failed to reproducibly validate the interaction by immunoprecipitation, GST pulldown and surface plasmon resonance (SPR), we cannot actually exclude a direct interaction, as there are technical complications with each of these approaches. The cytoplasmic domain of LRP1 interacts with multiple adaptor proteins and signalling proteins; while the 5kDa Tβ4 may participate, the complex may be too 'congested' to permit simultaneous binding of an anti-Tβ4 antibody, given the small size of the peptide. While pulldown and SPR methodologies obviate the need for antibody binding, they do not recreate the precise cellular context under which interaction potentially occurs, and which may be carefully regulated. Alternatively, an interaction may go undetected if it is transient and/or weak. A physical interaction is frequently inferred by proximity ligation assay, which requires proteins to be within 40nm and, in this regard, our data are supportive, although we cautiously conclude proximity, rather than a definitive protein-protein interaction. It is worth highlighting the functionally similar stabilin-2, an endocytic scavenger receptor which, like LRP1, internalizes coagulation factor VIII and LDL(55), amongst its many ligands, and contains NPxY motifs on its intracellular domain (56) . Stabilin-2 was identified by yeast two hybrid(57) and validated by biolayer interferometry(58) to be a "weak and fuzzy", yet specific, interactor of Tβ4, thus there is precedent for direct interaction with structurally and functionally similar receptors. Whether or not the proteins physically interact, we have validated an important functional interaction for Tβ4-controlled LRP1-PDGFRβ trafficking. Given the disease relevance of LRP1, not just in aortic disease but also in the pathogenesis of Alzheimer's disease (59) , further investigation into its internalization mechanism is warranted. Prevalence of aortic aneurysm is 5% amongst the elderly and treatment involves a high risk surgical procedure with no pharmacological therapeutic options. That Tβ4 can regulate endocytosis, even when administered exogenously (52) , raises the possibility of developing novel strategies to maintain differentiated VSMC phenotype and treat aortic disease. Martin Turner, Babraham Institute and have been previously described (7) . VSMC-specific Tβ4 knockdown mice were generated by crossing the previously described Hprt1-targeted, floxed Tβ4 shRNA line (7, 8) with tamoxifen-inducible Myh11 CreERT2 (25) , to generate Myh11 CreERT2 ;
Methods
Hprt Tβ4shRNA . VSMC-specific Lrp1 knockouts were generated by crossing the previously In vivo blood pressure measurement. One day after the MRI scan (exactly as previously described (61)), animals were anaesthetised with isoflurane (4%) and placed in supine position onto a heating plate with feedback control (Physitemp Instruments, NJ). Animals were kept at 37±1°C while oxygen and anaesthetics (1-2% isoflurane) were supplied via a nose cone (1 L/min). Body temperature and heart rate were recorded for the whole experiment using PowerLab with Chart 5 (ADInstruments, UK). A T-shaped middle-neck incision from mandible to the sternum was made. Blunt dissection was used to expose the left common carotid artery. A 5.0 Mersilk (Ethicon, NJ) suture was used to tie off the distal end of the artery while a micro vascular clip was used to occlude the proximal end of the exposed artery. A small incision near the distal end of the artery was made and a fluid filled tube (heparin; 100 U/mL diluted in 0.9% saline) with an inner diameter of 0.28 mm (Critchley Electrical Products Pty Ltd, Australia) was introduced into the artery and fixed in place with a suture. Following that, the micro vascular clip was removed and the arterial pressure was recorded using the MLT844 pressure transducer (ADInstruments, UK). After stabilisation of the signal for about 5-10 min an average of 1000 heart beats was used for analysis.
Atherosclerosis model. Age-matched (8) (9) (10) (11) (12) week old) mice, on the Apoe -/background, were fed on Western diet (21.4% fat; 0.2% cholesterol; Special Diets Services, Essex, UK) for up to 12 weeks. Mice were weighed weekly and, at harvest, serum collected for cholesterol analysis (by Charles River Laboratories). EdU(5-ethynyl-2'-deoxyuridine), prepared in 0.9% saline, was administered at a dose of 150mg/kg by intraperitoneal injection (4 doses over the 10 days prior to harvest).
Aneurysm model. [8] [9] [10] [11] [12] week old adult mice were infused with 1mg/kg/day Angiotensin II (Sigma) by subcutaneous implantation of an osmotic mini pump (Alzet) for 10 days. Animals were regularly monitored and weighed post-surgery until harvest.
Human tissue sampling
Subjects undergoing open abdominal aortic aortic aneurysm repair were prospectively recruited from the Oxford Abdominal Aortic Aneurysm (OxAAA) study. The study was approved by the 
